# US 2015/0105461 A1 · Metal Delivery Agents and Therapeutic Uses of the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105461 A1
- Document ID: US20150105461A1
- Status: Published application
- Kind: A1
- Application number: 14/571,938
- Filed: 2014-12-16
- Published: 2015-04-16
- Earliest claimed: 2006-11-20
- Assignees: The University of Melbourne
- Applicants: The University of Melbourne
- Inventors: Kevin J. Barnham; Paul S. Donnelly; Anthony R. White
- Web page: https://patentgrep.com/patent/US20150105461A1

## CPC

- A61K 31/555: containing heavy metals, e.g. hemin, hematin, melarsoprol
- A61K 31/145: having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2) (isothiourea A61K31/155)
- A61K 31/28: Compounds containing heavy metals
- A61K 31/30: Copper compounds
- A61K 31/315: Zinc compounds
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61P 27/12: for cataracts
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 33/06: Antimalarials
- A61P 35/00: Antineoplastic agents
- C07F 1/08: Copper compounds
- C07F 3/06: Zinc compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention relates to metal complexes, processes for their preparation and their use as pharmaceutical or veterinary agents, in particular for the treatment of conditions in which metal delivery can prevent, alleviate or ameliorate the condition. There are a number of clinical conditions which are caused by or associated with abnormal levels of metals (typically low metal levels). Conditions in of this type include cancer and conditions characterised by or associated with oxidative damage, more specifically neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease or Huntington's disease. The invention also relates to ligands useful in the preparation of metal complexes of this type.

## Claims

### Claim at position 1

-91. (canceled)

### Claim 92

A method comprising
providing a subject suffering from a disease selected from the group consisting of Parkinson's disease and amyotrophic lateral sclerosis; and
administering to the subject a therapeutically effective amount of a complex of Formula (I):
where:
the complex is symmetrical;
M is Cu or Zn;
R1 and R5 are each hydrogen;
R2 and R6 are each methyl, ethyl, or phenyl; and
R3 and R4 are each methyl.

### Claim 93 (depends on 92)

The method of claim 92 where the disease is Parkinson's disease.

### Claim 94 (depends on 92)

The method of claim 92 where the disease is amyotrophic lateral sclerosis.

### Claim 95 (depends on 92)

The method of claim 92 where M is Cu.

### Claim 96 (depends on 92)

The method of claim 92 where M is Zn.

### Claim 97 (depends on 92)

The method of claim 92 where R2 and R6 are each methyl.

### Claim 98 (depends on 92)

The method of claim 92 where R2 and R6 are each ethyl.

### Claim 99 (depends on 92)

The method of claim 92 where R2 and R6 are each phenyl.

### Claim 100 (depends on 93)

The method of claim 93 where M is Cu and R2 and R6 are each methyl.

### Claim 101 (depends on 93)

The method of claim 93 where M is Cu and R2 and R6 are each ethyl.

### Claim 102 (depends on 93)

The method of claim 93 where M is Cu and R2 and R6 are each phenyl.

### Claim 103 (depends on 93)

The method of claim 93 where M is Zn and R2 and R6 are each methyl.

### Claim 104 (depends on 93)

The method of claim 93 where M is Zn and R2 and R6 are each ethyl.

### Claim 105 (depends on 93)

The method of claim 93 where M is Zn and R2 and R6 are each phenyl.

### Claim 106 (depends on 94)

The method of claim 94 where M is Cu and R2 and R6 are each methyl.

### Claim 107 (depends on 94)

The method of claim 94 where M is Cu and R2 and R6 are each ethyl.

### Claim 108 (depends on 94)

The method of claim 94 where M is Cu and R2 and R6 are each phenyl.

### Claim 109 (depends on 94)

The method of claim 94 where M is Zn and R2 and R6 are each methyl.

### Claim 110 (depends on 94)

The method of claim 94 where M is Zn and R2 and R6 are each ethyl.

### Claim 111 (depends on 94)

The method of claim 94 where M is Zn and R2 and R6 are each phenyl.
